Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze® (C1 esterase inhibitor [human]) in the U.S. for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved in the U.S. for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx).  ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile infection.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including our regulatory filings in Europe related to Cinryze, including without limitation statements related to potential regulatory timelines, the likelihood of regulatory success including our ability to address the questions regarding our relationship with Sanquin and the scope of indications for which Cinryze may be approved. The EC may view the data regarding the use of Cinryze for acute treatment and / or prevention of HAE we hav
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... The western European automated endoscope reprocessor ... a replacement market with fewer new installations due ... partnerships are redefining competitive landscape in western ... details about revenue forecasts, unit shipments, market share ... country. The changing landscape makes it important to ...
(Date:9/22/2014)... -- Research and Markets  has announced the addition ... report to their offering. This newly ... up-to-date publication available covering the neurotechnology industry. The report ... and growth rates in four key segments of the ... forecasts the number of systems to be sold, worldwide ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3
... , Increased vaccination ... gaps remain, others must join effort , DAVOS, Switzerland ... announced today that their foundation will commit $10 billion ... deliver vaccines for the world,s poorest countries. , (Photo: ...
... , , REDWOOD CITY, Calif. ... today announced financial results for its fiscal second quarter and six months ... call at 4:30 p.m. Eastern Time to discuss the financial ... quarter, as we continued to transition the sales model for our cardiac ...
Cached Medicine Technology:Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 2Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 3Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 4Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 5Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 2Cardica Announces Fiscal 2010 Second Quarter Financial Results 3Cardica Announces Fiscal 2010 Second Quarter Financial Results 4Cardica Announces Fiscal 2010 Second Quarter Financial Results 5Cardica Announces Fiscal 2010 Second Quarter Financial Results 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 7Cardica Announces Fiscal 2010 Second Quarter Financial Results 8Cardica Announces Fiscal 2010 Second Quarter Financial Results 9
(Date:9/23/2014)... Sandpoint, Idaho (PRWEB) September 23, 2014 ... GunSafes.com is now offering SecureIt Tactical products ... prices. SecureIt Tactical, Inc. holds a good name in ... The company stores only the finest products and now ... tactical gun safes such as the MilSpec Tactical Safe ...
(Date:9/22/2014)... Vida Cannabis Corp . is ... Agreement with Florida-based AltMed LLC . , ... and technical expertise. They’ll also pool business development ... markets. , "We’re deeply impressed with the level ... Cannabis team as they work toward building the most ...
(Date:9/22/2014)... Detroit MI (PRWEB) September 23, 2014 ... 3 organization dedicated to serving patients, caregivers and families ... of Philip M. Fortier of Detroit, MI to its ... disease of the brain and spinal cord, and is ... addition to resembling Parkinson’s disease (MSA Type P), MSA ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Airbus Helicopters ... industry Monday for their efforts to improve safety and ... Award and the Program of the Year award, both ... Air Medical Transport Conference Annual Community Awards. , ... with the Jim Charlson Aviation Safety Award, given annually ...
(Date:9/22/2014)... United States District Judge Joseph ... mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) filed against defendant ... pretrial matters, issued an order in the multidistrict ... Products Liability Litigation (United States District Court for ... 2:12-md-02326)—requiring that four member cases be ready for ...
Breaking Medicine News(10 mins):Health News:GunSafes.com Now Offers Secure Tactical Range of Gun Safes 2Health News:Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2
... U.S. Environmental,Protection Agency has given $97,204 to ... providers and women of child-bearing age on,environmental health ... grants nationwide. In Ohio, the grant will be ... woman,s potential exposure to environmental,risks., The EPA ...
... N.J., Feb. 4 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP ... and chief operating officer, is scheduled to present at ... York on Monday, February,11, 2008 at 1:15 p.m. ET. ... a replay available approximately three hours after the,presentation has ...
... MONDAY, Feb. 4 (HealthDay News) -- Drug-coated stents are better ... research finds. , "There are two messages I would take ... professor of cardiology at Wake Forest University and lead author ... Journal of the American College of Cardiology. "The ...
... has,agreed to settle for $2.5 million, plus interest, ... program, the Justice Department,announced today. The settlement is ... Medical Center is currently in bankruptcy., The ... to Medicare patients in order to obtain enhanced,reimbursement ...
... ALTO, Calif., Feb. 4 Formerly conjoined twins,Yurelia ... at Stanford and are now home in Costa ... Children,s last Wednesday (30) and went,to Southern California ... sponsor the girls, trip. Today (4), they flew ...
... Those with poor balance, dementia, vision loss most in peril, ... -- Certain people are at high risk for accidental falls ... number of fall-related injuries and deaths in the United States, ... States, accidental falls result in 1.8 million emergency room visits ...
Cached Medicine News:Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 2Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 3Health News:Buyer of Bayonne Hospital to Pay U.S. $2.5 Million to Resolve Allegations of Medicare Fraud 2Health News:Formerly Conjoined Twins Leave Packard Children's Hospital; Heading Home to Costa Rica 2Health News:New Guideline Urges Screening for Fall Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: